Synaffix B.V.: Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ...
AMSTERDAM, BASEL, Switzerland and INGELHEIM, Germany, Jan. 9, 2025 /PRNewswire/ -- Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing ...
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology
Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing its clinical-stage ...